199 related articles for article (PubMed ID: 34655415)
1. The changing microRNA landscape by color and cloudiness: a cautionary tale for nipple aspirate fluid biomarker analysis.
Patuleia SIS; van der Wall E; van Gils CH; Bakker MF; Jager A; Voorhorst-Ogink MM; van Diest PJ; Moelans CB
Cell Oncol (Dordr); 2021 Dec; 44(6):1339-1349. PubMed ID: 34655415
[TBL] [Abstract][Full Text] [Related]
2. The Physiological MicroRNA Landscape in Nipple Aspirate Fluid: Differences and Similarities with Breast Tissue, Breast Milk, Plasma and Serum.
Patuleia SIS; van Gils CH; Oneto Cao AM; Bakker MF; van Diest PJ; van der Wall E; Moelans CB
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187146
[TBL] [Abstract][Full Text] [Related]
3. Nipple aspirate fluid-A liquid biopsy for diagnosing breast health.
Shaheed SU; Tait C; Kyriacou K; Mullarkey J; Burrill W; Patterson LH; Linforth R; Salhab M; Sutton CW
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28488344
[TBL] [Abstract][Full Text] [Related]
4. Nipple aspirate fluid color is associated with breast cancer.
Sauter ER; Winn JN; Dale PS; Wagner-Mann C
Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197
[TBL] [Abstract][Full Text] [Related]
5. Potential correlation between tumor aggressiveness and protein expression patterns of nipple aspirate fluid (NAF) revealed by gel-based proteomic analysis.
Brunoro GV; Ferreira AT; Trugilho MR; Oliveira TS; Amêndola LC; Perales J; Valente RH; Gallo CV; Pagnoncelli D; Neves-Ferreira AG
Curr Top Med Chem; 2014; 14(3):359-68. PubMed ID: 24304313
[TBL] [Abstract][Full Text] [Related]
6. New horizon for breast cancer biomarker discoveries: What might the liquid biopsy of nipple aspirate fluid hold?
Mannello F
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28627779
[TBL] [Abstract][Full Text] [Related]
7. Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid.
Shidfar A; Fatokun T; Ivancic D; Chatterton RT; Khan SA; Wang J
Horm Cancer; 2016 Aug; 7(4):252-9. PubMed ID: 27094399
[TBL] [Abstract][Full Text] [Related]
8. Proliferative epithelial disease identified in nipple aspirate fluid and risk of developing breast cancer: a systematic review.
Hornberger J; Chen SC; Li Q; Kakad P; Quay SC
Curr Med Res Opin; 2015 Feb; 31(2):253-62. PubMed ID: 25405383
[TBL] [Abstract][Full Text] [Related]
9. The volume of nipple aspirate fluid is not affected by 6 months of treatment with soy foods in premenopausal women.
Maskarinec G; Morimoto Y; Conroy SM; Pagano IS; Franke AA
J Nutr; 2011 Apr; 141(4):626-30. PubMed ID: 21325473
[TBL] [Abstract][Full Text] [Related]
10. Influence of diet on nipple aspirate fluid production and estrogen levels.
Morimoto Y; Conroy SM; Pagano IS; Franke AA; Stanczyk FZ; Maskarinec G
Food Funct; 2011 Nov; 2(11):665-70. PubMed ID: 21986640
[TBL] [Abstract][Full Text] [Related]
11. Elevated miR-29c-5p Expression in Nipple Aspirate Fluid Is Associated with Extremely High Mammographic Breast Density.
Vissers TACM; Piek L; Patuleia SIS; Duinmeijer AJ; Bakker MF; van der Wall E; van Diest PJ; van Gils CH; Moelans CB
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954468
[TBL] [Abstract][Full Text] [Related]
12. Nipple aspirate fluid proteome of healthy females and patients with breast cancer.
Pavlou MP; Kulasingam V; Sauter ER; Kliethermes B; Diamandis EP
Clin Chem; 2010 May; 56(5):848-55. PubMed ID: 20348408
[TBL] [Abstract][Full Text] [Related]
13. Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations.
Chatterton RT; Khan SA; Heinz R; Ivancic D; Lee O
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):275-9. PubMed ID: 20056648
[TBL] [Abstract][Full Text] [Related]
14. Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial.
Thompson PA; Hsu CH; Green S; Stopeck AT; Johnson K; Alberts DS; Chow HH
Cancer Prev Res (Phila); 2010 Jan; 3(1):101-7. PubMed ID: 20051377
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of nipple aspirate fluid (NAF): Exploring the complementarity of different peptide fractionation strategies.
Brunoro GV; Carvalho PC; Ferreira AT; Perales J; Valente RH; de Moura Gallo CV; Pagnoncelli D; Neves-Ferreira AG
J Proteomics; 2015 Mar; 117():86-94. PubMed ID: 25638022
[TBL] [Abstract][Full Text] [Related]
16. Differential proteomic comparison of breast cancer secretome using a quantitative paired analysis workflow.
Brunoro GVF; Carvalho PC; Barbosa VC; Pagnoncelli D; De Moura Gallo CV; Perales J; Zahedi RP; Valente RH; Neves-Ferreira AGDC
BMC Cancer; 2019 Apr; 19(1):365. PubMed ID: 30999875
[TBL] [Abstract][Full Text] [Related]
17. Estrogen levels in nipple aspirate fluid and serum during a randomized soy trial.
Maskarinec G; Ollberding NJ; Conroy SM; Morimoto Y; Pagano IS; Franke AA; Gentzschein E; Stanczyk FZ
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1815-21. PubMed ID: 21742946
[TBL] [Abstract][Full Text] [Related]
18. Genetic Determinants of Nipple Aspiration Fluid Yield.
Shidfar A; Wang J; Wiesenfeld E; Zhang W; Scholtens D; Fought A; Chatterton RT; Khan SA
Ann Surg Oncol; 2016 Aug; 23(8):2487-93. PubMed ID: 27027309
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors.
Chan AA; Bashir M; Rivas MN; Duvall K; Sieling PA; Pieber TR; Vaishampayan PA; Love SM; Lee DJ
Sci Rep; 2016 Jun; 6():28061. PubMed ID: 27324944
[TBL] [Abstract][Full Text] [Related]
20. Protein identification from dried nipple aspirate fluid on Guthrie cards using mass spectrometry.
Delmonico L; Areias VR; Pinto RC; Matos Cda S; Rosa MF; De Azevedo CM; Alves G
Mol Med Rep; 2015 Jul; 12(1):159-64. PubMed ID: 25760982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
